Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Exercise | $0 | SEC | |
| Award | — | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $0 | SEC | |
| AwardD | $0 | SEC | |
| Exercise | $107.8K | SEC | |
| ExerciseD | $0 | SEC | |
| Other | $107.8K | SEC | |
| Award | — | SEC | |
| AwardD | $0 | SEC | |
| Exercise | — | SEC | |
| ExerciseD | $0 | SEC | |
| Buy | $2.3K | SEC | |
| Buy | $2.9K | SEC | |
| Buy | $5.7K | SEC | |
| Buy | $3.6K | SEC | |
| Buy | $5.7K | SEC | |
| Buy | $2.9K | SEC | |
| Buy | $2.9K | SEC | |
| Buy | $2.9K | SEC | |
| Buy | $2.1K | SEC | |
| Buy | $2.9K | SEC | |
| Buy | $581 | SEC | |
| Exercise | $134.5K | SEC | |
| Exercise | $93.9K | SEC |